Ignite Creation Date:
2024-07-17 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06481007
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-06-22
Brief Title:
ALgerian Cholecystectomy Outcomes and Determinants Study AL-CODS
Sponsor:
University of Oran 1
Organization:
University of Oran 1
Study Overview
Official Title:
Algerian Cholecystectomy Outcomes and Determinants Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AL-CODS
Brief Summary:
Cholecystectomy the surgical removal of the gallbladder is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis gallstones cholecystitis inflammation of the gallbladder and biliary dyskinesia While generally considered safe this surgery can be associated with significant morbidity and mortality particularly in certain populations or healthcare settings Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices
In Algeria the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria Such data is essential for benchmarking current practices identifying areas for improvement and ultimately enhancing patient safety and surgical efficacy
In Algeria the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria Such data is essential for benchmarking current practices identifying areas for improvement and ultimately enhancing patient safety and surgical efficacy
Detailed Description:
This study seeks to bridge this knowledge gap by offering detailed data on 30-day postoperative outcomes after cholecystectomy for benign gallbladder diseases in Algeria This information is crucial for benchmarking existing practices pinpointing areas for enhancement and ultimately improving patient safety and surgical effectiveness
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None